SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Visium Asset Management, LP (Last) (First) (Middle) 950 THIRD AVENUE (Street) NEW YORK NY 10022 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 09/14/2007	3. Issuer Name and Ticker or Trading Symbol OSCIENT PHARMACEUTICALS CORP [ OSCI ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director X 10% Owner Officer (give title below) Other (specify below)	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person X Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
OSCI 3 1/2 4/11 Convertible Debt	05/10/2004	04/15/2011	Common Stock	1,777,778	$13.5	I	See Footnote(1)

1. Name and Address of Reporting Person* Visium Asset Management, LP (Last) (First) (Middle) 950 THIRD AVENUE (Street) NEW YORK NY 10022 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Jacob Gottlieb (Last) (First) (Middle) C/O VISIUM ASSET MANAGEMENT, LP 950 THIRD AVENUE (Street) NEW YORK NY 10022 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* JG ASSET, LLC (Last) (First) (Middle) C/O VISIUM ASSET MANAGEMENT, LP 950 THIRD AVENUE (Street) NEW YORK NY 10022 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

Explanation of Responses:

1. Jacob Gottlieb ("Gottlieb") is the Managing Member of JG Asset, LLC ("JG") which is the General Partner of Visium Asset Management, LP ("VAM"). VAM has indirect beneficial ownership as the investment manager of pooled investment vehicles. VAM, JG and Gottlieb disclaim beneficial ownership as to the Securities, except to the extent of his or its pecuniary interests therein. Neither the filing of this Schedule nor any of its contents shall be deemed to constitute an admission that any of the other individual officers and members of VAM or JG is, for any purpose, the beneficial owner of any of the Securities.

	/s/ MARK GOTTLIEB, AUTHORIZED SIGNATORY FOR VISIUM ASSET MANAGEMENT L.P.	11/08/2007
	/s/ MARK GOTTLIEB, AUTHORIZED FOR JG ASSET, LLC	11/08/2007
	/s/ MARK GOTTLIEB, AUTHORIZED REPRESENTATIVE AND EXECUTIVE OFFICER OF VISIUM ASSET MANAGEMENT, LP FOR JACOB GOTTLIEB	11/08/2007
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.